Arkolith/Insider Trading/ABCL/Form 4

Booth Andrew

Chief Financial OfficerAbCellera Biologics Inc. (ABCL) · full profile →Form 4 · filed May 26, 2023
Net Buying
Open-Market Buys
$99K
Open-Market Sells
$0
Net Open-Market Flow
$99K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 26, 2023Buy(P)15K$6.85$99K153K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-032484) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML